Anxiety-induced failure in erectile response to intracorporeal prostaglandin-E1 in non-organic male impotence: A new diagnostic approach

International Journal of Andrology

Volumn 19, Issue 5, 1996, Pages 307-313

  Aversa, A ^a   Rocchietti March, M ^a   Caprio, M ^a   Giannini, D ^a   Isidori, A ^a   Fabbri, A ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Alprostadil; Diagnostic tests; Erectile dysfunction; Intracavernous injection,; Phentolamine; Stress

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; METARAMINOL; PHENTOLAMINE; PHENTOLAMINE MESYLATE; PROSTAGLANDIN E1;

AFFECTIVE NEUROSIS; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG MIXTURE; HUMAN; IMPOTENCE; INTRACAVERNOUS DRUG ADMINISTRATION; MALE; PENIS ERECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

EID: 0030444613     PISSN: 01056263     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2605.1996.tb00481.x     Document Type: Article

References (31)

1. Allen, R. P., Smolev, J. K., Engel, R. M. & Brendler, C. B. (1993) Comparison of Rigiscan and formal nocturnal penile tumescence testing in the evaluation of erectile rigidity. Journal of Urology, 149, 1265-1268.
2. Bernard, F., Stief, C. G., Bosch, R., Diederichs, W., Lue, T. F. & Tanagho, E.A. (1988) Systemic infusion of epinephrine: its effect on erection. In: Proceedings of the 6th Biennal International Symposium for Corpus Cavernosum Revascularization, Boston, Massachusetts, p. 16 (abstract).
3. Carroll, B. J. (1980) Dexamethasone suppression test in depression. Lancet, 8206, 1249-1255.
4. 1 as treatment for erectile dysfunction. Journal of Urology, 153, 80-81.
5. Donatucci, C. F. & Lue, T. F. (1992) The combined intracavernous injection and stimulation test: diagnostic accuracy. Journal of Urology, 148, 61-62.
6. Fabbri, A., Jannmi, E. A., Ulisse, S., Gnessi, L., Moretti, C., Frajese, G. & Isidori, A. (1988) Low serum bioactive luteinizing-hormone in non organic male impotence: possible relationship with altered gonadotropin-releasing-hormone pulsatility. Journal of Clinical Endocrinology and Metabolism, 67, 867-875.
7. Fabbri, A., Jannini, E. A., Gnessi, L., Moretti, C., Ulisse, S., Franzese, A., Lazzari, R., Fraioli, F., Frajese, G. & Isidori, A. (1989) Endorphins in male impotence: evidence for naltrexone stimulation of erectile activity in patient therapy. Psychoneuroendocrinology, 14, 103-111.
8. Glantz, F. A., (1988) Statistics per Discipline Biomediche, 2nd edn. McGraw & Hill, Libri Italia srl.
9. Godschalk, M. F., Chen, J., Katz, P. G. & Mulligan, T. (1994) Treatment of erectile failure with prostaglandin-E1: a double-blind, placebo-controlled, dose-response study. Journal of Urology, 151, 1530-1532.
10. 1 in men with erectile dysfunction. Psychosomatic Medicine, 57, 336-344.
11. Hedlund, J., Anderson, K. E., Holmquist, F. & Uski, T. (1989) Effects of the thromboxane receptor antagonist AH 23848 on human isolated corpus cavernosum. International Journal of Impotence Research, 1, 19-23.
12. Kifor, R., Vickers, M., Sullivan, M., Williams, G. H. & Dlhuy, R. (1995) Tissue angiotensin II and impotence. In: Proceedings and Abstracts of the 77th International Congress of the Endocrine Society, Washington DC, 14-17 June, p. 325.
13. Kim, S. C. & Oh, M. M. (1992) Norepinephrine involvement in response to intracorporeal injection of papaverine in psychogenic impotence. Journal of Urology, 147, 1530-1532.
14. Korenman, S. G. (1995) Advances in the understanding and management of erectile dysfunction. Journal of Clinical Endocrinology and Metabolism, 80, 1985-1988.
15. 1 for organic impotence. Nippon Hinyokika Gakkai Zasshi, 77, 954-962.
16. Levin, R. M. & Wein, A. J. (1980) Adrenergic alpha receptors out-number beta receptors in human penile corpus cavernosum. Investigative Urology, 18, 225-228.
17. Levine, S. B., Althof, S. E., Turner, L. A., Risen, C. B., Bodner, D. R., Kursh, E. D. & Resnick, M. I. (1989) Side-effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence. Journal of Urology, 141, 54-57.
18. Linet, O. I. & Ogrinc, F. G. for the Alprostadil study group (1996) Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. New England Journal of Medicine, 334, 873-877.
19. Pescatori, E., Hatzichristou, D. G., Namburi, S. & Goldstein, I. (1994) A positive intracavernous injection test implies a normal veno-occlusive but not necessarily normal arterial function: a haemodynamic study. Journal of Urology, 151, 1209-1216.
20. Rocco, A., Mon, F., Baldelli, R., Aversa, A., Munizzi, M. R., Nardone, M. R., Fabbrini, A. & Falaschi, P. (1993) Effect of chronic bromocriptine treatment on psychological profile of patients with PRL-secreting pituitary adenomas. Psychoneuroendocrinology, 18, 57-66.
21. Saenz de Tejada, I., Carson, M. P., De Las Morenas, A., Goldstein, I. & Traish, A. M. (1991) Endothelin: localization, synthesis, activity and receptor types in human penile corpus cavernosum. American Journal of Physiology, 26, H1078-H1085.
22. Sanavio, E., Bertolotti, G., Michielin, P., Vidotto, G. & Zotti, A. M. (1986) CBA 2.0-Scale Primarie. OS, Firenze.
23. 1 in erectile dysfunction. British Journal of Clinical Pharmacology, 28, 567-570.
24. Spielberger, C. D., Gorsuch, R. & Lushene, R. E. (1970) Manual for the State Trait Anxiety Inventory. Consulting Psychologist Press, Palo Alto, CA.
25. Traish, A. M., Netsuwan, N., Daley, J., Padman-Nathan, H., Goldstein, I. & Saenz de Tejada, I. (1995) A heterogeneous population of alpha-1 adrenergic receptor subtype mediates contraction of human corpus cavernosum smooth muscle to norepinephrine. Journal of Urology, 153, 222-227.
26. van Halen, H., Peskar, B. A., Sticht, G. & Hertfelder, H. (1994) Pharmacokinetics of vasoactive substances administered into the human corpus cavernosum. Journal of Urology, 151, 1227-1230.
27. Virag, R. (1984) Intracavernous injection of papaverine as a diagnostic and therapeutic method in erectile failure. Angiology, 35, 79-83.
28. von Heuler, U. S. (1964) Quantitation of stress by catecholamine analysis. Clinical Pharmacology and Therapeutics, 5, 398-401.
29. von Heyden, B., Donatucci, C. E, Kaula, N. & Lue, T. F. (1993a) Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose. Journal of Urology, 149, 1288-1290.
30. 1 dose-response study in man. Journal of Urology, 150, 1825-1828.
31. Zung, W. W. K. (1970) Treatment prediction in depression using a self-rating scale. Biological Psychiatry, 2, 321-329.